Vaccine Cryoprotectants Market

Future Market Insights

Vaccine Cryoprotectants Market

Key Insight

The global vaccine cryoprotectants market is projected to grow from USD 646.8 million in 2025 to USD 1,097.4 million by 2035, at a CAGR of 5.4%. By product type, sugars will lead with a 37.6% market share, while by application, mRNA & LNP vaccines will dominate with a 26.9% share in 2025.

December 04, 2025

Anurag Sharma

250 Pages

Cite this Report

Vaccine Cryoprotectants Market

https://www.futuremarketinsights.com/reports/vaccine-cryoprotectants-market

License

Buy Now

Summary ToC Companies

Key Players

Avantor
DFE Pharma
Hayashibara (Nagase) Trehalose
Merck KGaA (MilliporeSigma)
Pfanstiehl (Trehalose/Mannitol)
Roquette (Polyols/Trehalose)
SPI Pharma
Thermo Fisher Scientific (Gibco)

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Vaccine Cryoprotectants Market

Key Players

Similar Industry Reports